Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04540705
Title A Study to Evaluate the Triplet Combination of Bempegaldesleukin (Bempeg/NKTR-214) Plus Nivolumab and Axitinib and the Doublet Combination of Nivolumab and Axitinib in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread (PIVOT IO 011)
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | DEU | CAN

Facility Status City State Zip Country Details
Local Institution - 0005 Springdale Arkansas 72762 United States Details
Local Institution Louisville Kentucky 40202 United States Details
Local Institution - 0001 Saint Louis Missouri 63110 United States Details
Local Institution - 0009 New York New York 10065 United States Details
Local Institution Portland Oregon 97213 United States Details
Local Institution Nashville Tennessee 37232 United States Details
Local Institution - 0014 Houston Texas 77030-3721 United States Details
Local Institution - 0007 Seattle Washington 98109 United States Details
Local Institution - 0025 Mar del Plata Buenos Aires 7600 Argentina Details
Local Institution - 0075 Río Cuarto Córdoba X5800ALB Argentina Details
Local Institution - 0026 Buenos Aires 1419 Argentina Details
Local Institution - 0024 San Juan 5400 Argentina Details
Local Institution - 0030 Belo Horizonte Minas Gerais 30130-090 Brazil Details
Local Institution - 0035 Curitiba Parana 80730-150 Brazil Details
Local Institution - 0028 Porto Alegre RIO Grande DO SUL 91350-200 Brazil Details
Local Institution - 0036 Santa Cruz do Sul RIO Grande DO SUL 96830-180 Brazil Details
Local Institution - 0032 Barretos SAO Paulo 14784400 Brazil Details
Local Institution - 0029 Sao Jose do Rio Preto SAO Paulo 15090-000 Brazil Details
Local Institution - 0056 Edmonton Alberta T6G 1Z2 Canada Details
Local Institution - 0015 Vancouver British Columbia V5Z 4E6 Canada Details
Local Institution - 0022 St. Johns Newfoundland and Labrador A1B 3V6 Canada Details
Local Institution - 0008 Toronto Ontario M5G 1Z5 Canada Details
Local Institution - 0079 Marseille 13273 France Details
Local Institution - 0042 Essen 45147 Germany Details
Local Institution - 0045 Hannover 30625 Germany Details
Local Institution - 0040 Jena 07747 Germany Details
Local Institution - 0044 Munich 81675 Germany Details
Local Institution - 0041 Nürnberg 90419 Germany Details
Local Institution - 0046 Würzburg 97080 Germany Details
Local Institution - 0048 Mexico City Distrito Federal 14080 Mexico Details
Local Institution - 0050 Zapopan Jalisco 45070 Mexico Details
Local Institution - 0049 Monterrey Nuevo LEON 66460 Mexico Details
Local Institution - 0055 Queretaro 76000 Mexico Details
Local Institution - 0059 Moscow 115478 Russian Federation Details
Local Institution - 0052 Moscow 121205 Russian Federation Details
Local Institution - 0087 Moscow 121359 Russian Federation Details
Local Institution - 0051 Novosibirsk 630099 Russian Federation Details
Local Institution - 0085 Omsk 644013 Russian Federation Details
Local Institution - 0058 Saint Petersburg 197758 Russian Federation Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field